Overview of Digital Therapeutics and Reimbursement Digital therapeutics (DTx) are evidence-based software interventions prescribed to treat or manage medical conditions.

In January 2025, a long-awaited experiment in European healthcare quietly began. For the first time, all EU countries have started

Advances in artificial intelligence (AI) are rapidly transforming drug development and clinical trials. Medicines regulatory agencies worldwide have responded by

During the week of July 21–25, 2025, the biopharmaceutical industry saw a flurry of deal-making worldwide. This included major

Most biotech professionals are familiar with science and R&D, but deal press releases often include financial jargon that

Disclaimer: This analysis represents an opinion based on publicly available information and should not be considered investment advice. Please conduct

BioPharma Credit PLC (BPCR) is a London-listed investment trust specializing in debt financing for the life sciences sector. Managed by

Introduction – Deals as the New Discovery Platform biotech companies today often make headlines not for proven drugs, but for deals

Biopharma royalty deals are financial transactions where an investor purchases the right to receive future royalty payments from a drug

For large pharmaceutical firms, the week’s deals underscored a willingness to spend on promising science – especially to hedge against